glp-1 adherence therapies and mortality risk: Implications for life insurers High GLP-1 adherence in Yazen's

The liver utilizes a critical two-step process known as Phase I and Phase II detoxification

People who take semaglutide (the active ingredient in Ozempic and Wegovy) or tirzepatide (Mounjaro) frequently report: Nausea Vomiting Constipation or diarrhea Fatigue Headaches Decreased appetite These side effects can be uncomfortable, but theyre generally short-term and manageable for most patients

doi: 10.1016/j.bpj.2015.07.051

Foster, R

Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels

A statement that the patient was counseled on the nature of compounded drugs, storage, and potential side effects